RxDoctor Payments Data

Samuel Penziner

Hospitalist · Los Angeles, CANPI 1073900809

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,242 of the $1,473 with a category attached, or 84.3%. Every reported general payment came from a single manufacturer, Merck. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,473in general payments, 2019–2025

Across 8 payments — averaging $184.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
$2,452,115in research payments, 2019–2025

Across 1,682 payments — averaging $1457.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.4M
  • AstraZeneca$331K
  • Chiesi USA, Inc.$292K
  • Sanofi Pasteur Inc.$172K
  • Eli Lilly$155K
  • Pfizer$50K
  • plus $50K from 5 others

What the payments were for

  • Travel & lodging$1,24284%
  • Food & beverage$23216%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$1,473

How this compares

$1,473 in reported general payments places this provider in the 90th percentile of 2,469 hospitalist providers in California.

See all hospitalist providers in California

Other hospitalist in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →